Ethris Competitors and Similar CompaniesClear all
Ambrx's competitors and similar companies include Ocugen.
 Ambrx Ambrx is a biopharmaceutical company that discovers and develops engineered precision biologics therapeutics using an expanded genetic code. |  Ocugen Ocugen is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing therapies to treat eye diseases | |
Founding Date | Founding Date 2003 | Founding Date 2013 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations San Diego, US HQ | Locations Malvern, US HQ |
Employees | Employees 70 | Employees 84425% increase |
Valuation ($) | Valuation ($) 1.8 b | Valuation ($) 292.1 m |
Financial | ||
Revenue (est.) | Revenue (est.) $7.4m (FY, 2022) | Revenue (est.) $4.4m (FY, 2025) |
Net income | Net income ($78m) (FY, 2022) | Net income ($67.8m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Ocugen
HQ
Malvern, US
Employees
84
Ocugen is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing therapies to treat eye diseases
View company